BiotechTube
Home/Zelluna Immunotherapy/Luise Weigand
LW

Luise Weigand

Chief Scientific Officer

Zelluna Immunotherapy

Therapeutic Areas

OncologySolid Tumors

Zelluna Immunotherapy Pipeline

DrugIndicationPhase
Proprietary TCR-NK PlatformUndisclosed Solid TumorsPreclinical

Leadership Team at Zelluna Immunotherapy

NH
Namir Hassan
Chief Executive Officer
GC
Geir Christian Melen
Chief Financial Officer
AH
Anders Holm
Chief Operating Officer & Head of Business Development
EG
Emilie Gauthy
Chief Technology Officer/Head of CMC
WH
Wolf Hervé Fridman
Scientific Advisory Board Member
OH
Omid Hamid
Scientific Advisory Board Member
DJ
Dirk Jäger
Scientific Advisory Board Member
View full Zelluna Immunotherapy profile